News & Events

Introduction to Radiation Therapy

Introduction to Radiation Therapy

Lung cancer survivor Jill Feldman joins radiation therapy experts Drs. Drew Moghanaki and Kristin Higgins to provide an overview of radiation therapy – including discussions of when this treatment is recommended, how the treatment is administered, and which side effects are most common.

Caregiver Resources Starter Kit: 5 Resources Caregivers Should Access upon their Loved One’s Diagnosis

Caregiver Resources Starter Kit: 5 Resources Caregivers Should Access upon their Loved One’s Diagnosis

Navigating a lung cancer diagnosis can feel overwhelming not only to the patient but to their caregiver as well. It’s normal to feel lost or confused and not know where to start or what resources to ask for. Because a cancer diagnosis is a family diagnosis, LUNGevity wants caregivers to know they don’t have to go through it alone. There are resources available to help caregivers take care of their loved ones as well as themselves. Here are 5 important caregiver resources to help with your loved…

World Lung Cancer Day and the Changing Landscape of Lung Cancer

World Lung Cancer Day and the Changing Landscape of Lung Cancer

For decades, lung cancer was synonymous with low survival rates, limited treatment options, and poor quality of life for those living with the disease. Each year, more than 236,000 people in the US are diagnosed with lung cancer. The high incidence of lung cancer means scientific research into new therapies is critical, both for current survivors and those who will be diagnosed in the future. Thankfully, the landscape of lung cancer is changing for the better. Due to progress in research and…

Key Findings from ASCO 2022

Key Findings from ASCO 2022

Upal Basu Roy, PhD, MPH, LUNGevity's Executive Director of Research, speaks with Charles Rudin, MD, PhD, about the key findings from the recent meeting of the American Society for Clinical Oncology (ASCO) and what they mean for the lung cancer community.

We're Live-Tweeting from ASCO June 3-7!

We're Live-Tweeting from ASCO June 3-7!

LUNGevity’s Dr. Upal Basu Roy and Dr. Amy Moore will be live-tweeting from the American Society of Clinical Oncology (ASCO) annual meeting. Follow LUNGevity on Twitter and the hashtags #ASCO22 and #LCSM to be a part of the action. Times and topics of live-tweeted sessions are as follows: Fri, Jun 3, 2022 | 2:00 PM – 5:00 PM EDT | Lung Cancer—Non-Small Cell Metastatic  Sun, Jun 5, 2022 | 9:00 AM – 10:15 AM EDT | Treatment Sequencing in Resectable Lung Cancer…

Lung Cancer Treatment Landscape: New Options and Ongoing Challenges

Lung Cancer Treatment Landscape: New Options and Ongoing Challenges

Drs. Upal Basu Roy, Amy Moore, and Dhru Deb discuss their recent publication in which they presented an analysis of the lung cancer drug pipeline. They talk about what it means for patients, new drugs under development for NSCLC and SCLC, and some of the ongoing challenges and opportunities this rapid growth means for the lung cancer community.

Tips for Better Sleep

Tips for Better Sleep

Sleep tips session with our sleep expert, Peggy Burhenn.

University of Michigan ALK Positive Webinar

University of Michigan ALK Positive Webinar

Amy Moore, PhD, LUNGevity's Vice President, Global Engagement and Patient Partnerships, conducts this webinar on ALK-positive lung cancer.

New Options in Adjuvant Therapy for Early-Stage NSCLC

New Options in Adjuvant Therapy for Early-Stage NSCLC

Historically, surgery has been the most effective treatment for patients with early-stage non-small cell lung cancer (NSCLC). While technological improvements, such as the development of minimally invasive techniques (such as video-assisted thoracoscopic surgery or VATS), have made surgeries safer for patients, the ability to cure early-stage NSCLC patients hasn’t improved significantly in recent decades. Even after successful surgeries that completely remove the visible tumor, about half of…

Highlights of the 2022 AACR meeting

Highlights of the 2022 AACR meeting

The American Association for Cancer Research (AACR) 2022 meeting was held in New Orleans from April 9 to 13. Doctors and researchers worldwide joined together virtually and in person to make this year’s meeting one of the largest gatherings since the start of the pandemic. They shared the many exciting developments in cancer research and treatment that emerged over the last year. This year’s meeting is another testament to “Science doesn’t stop, and scientists never sleep!” Here, we discuss…